Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Albrich, Werner C; Harbarth, Stéphan Juergen

doi:10.1007/s00134-015-3978-8

Scientific article

English

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Contributors

Albrich, Werner C; Harbarth, Stéphan Juergen

Published in

Intensive care medicine, vol. 41, no. 10, p. 1739-1751

Publication date

2015

Abstract

Patients in the intensive care unit (ICU) frequently receive prolonged or even unnecessary antibiotic therapy, which selects for antibiotic-resistant bacteria. Over the last decade there has been great interest in biomarkers, particularly procalcitonin, to reduce antibiotic exposure.

UNIGE affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

UNIGE research groups

Résistance aux antibiotiques (866)

Citation (ISO format)

ALBRICH, Werner C, HARBARTH, Stéphan Juergen. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. In: Intensive care medicine, 2015, vol. 41, n° 10, p. 1739–1751. doi: 10.1007/s00134-015-3978-8

Article (Published version)

Identifiers

PID : unige:77979
DOI : 10.1007/s00134-015-3978-8
PMID : 26194026

Journal ISSN

0342-4642

582views

0downloads

Creation

13/10/2015 10:08:00

First validation

13/10/2015 10:08:00

Update

13/10/2025 21:09:20

Status update

08/10/2024 09:15:50

Last indexation

10/11/2026 13:16:40

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Contributors

Published in

Publication date

Abstract

UNIGE affiliation entities

UNIGE research groups

Citation (ISO format)

Main files (1)

Identifiers

Journal ISSN

Technical informations

Creation

First validation

Update

Status update

Last indexation